Safety results from a 12-week open-label, multicenter study of sodium oxybate in patients with narcolepsy

被引：0
|
作者：
Mamelak, M. [1 ]
Swick, T. [2 ]
Emsellem, H. [3 ,4 ]
Montplaisir, J. [5 ]
Lai, C. [6 ]
Black, J. [6 ,7 ]
机构：
[1] Univ Toronto, Dept Psychiat, Toronto, ON, Canada
[2] Neurol & Sleep Med Consultants Houston, Houston, TX USA
[3] George Washington Univ, Sch Med, Washington, DC USA
[4] Ctr Sleep & Wake Disorders, Chevy Chase, MD USA
[5] Univ Montreal, Dept Psychiat, Montreal, PQ H3C 3J7, Canada
[6] Jazz Pharmaceut Inc, Palo Alto, CA USA
[7] Stanford Sleep Med Ctr, Redwood City, CA USA
来源：
JOURNAL OF SLEEP RESEARCH | 2014年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P913
引用
收藏
页码：289 / 289
页数：1
相关论文
共 50 条
  • [1] A 12-Week, Open-Label Study Evaluating Sodium Oxybate (SXB) in Patients with Narcolepsy
    Mamelak, Mortimer
    Swick, Todd
    Emsellem, Helene
    Montplaisir, Jacques
    Lai, Chinglin
    Black, Jed
    [J]. ANNALS OF NEUROLOGY, 2014, 76 : S131 - S132
  • [2] A 12-week open-label, multicenter study evaluating the safety and patient-reported efficacy of sodium oxybate in patients with narcolepsy and cataplexy
    Mamelak, Mortimer
    Swick, Todd
    Emsellem, Helene
    Montplaisir, Jacques
    Lai, Chinglin
    Black, Jed
    [J]. SLEEP MEDICINE, 2015, 16 (01) : 52 - 58
  • [3] Safety and Effectiveness of Lurasidone in Patients with Schizophrenia: A 12-Week, Open-Label Extension Study
    Iyo, Masaomi
    Ishigooka, Jun
    Nakamura, Masatoshi
    Sakaguchi, Reiko
    Okamoto, Keisuke
    Mao, Yongcai
    Tsai, Joyce
    Fitzgerald, Alison
    Takai, Kentaro
    Higuchi, Teruhiko
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2021, 17 : 2683 - 2695
  • [4] A 12-month, open-label, multicenter extension trial of orally administered sodium oxybate for the treatment of narcolepsy
    Black, J
    Guilleminault, C
    Bogan, R
    Feldman, N
    Hagaman, M
    Hertz, G
    Iyer, V
    Kathawalla, S
    Lankford, A
    Mitler, M
    Hayduk, R
    Sahota, P
    Roth, T
    Scharf, M
    Scrima, L
    Schwartz, J
    Zammit, G
    [J]. SLEEP, 2003, 26 (01) : 31 - 35
  • [5] Effectiveness and Safety of Donepezil in Hispanic Patients with Alzheimer's Disease: A 12-Week Open-Label Study
    Lopez, Oscar L.
    Mackell, Joan A.
    Sun, Yijun
    Kassalow, Laurent M.
    Xu, Yikang
    McRae, Thomas
    Li, Honglan
    [J]. JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2008, 100 (11) : 1350 - 1358
  • [6] Trazodone for the treatment of fibromyalgia: an open-label, 12-week study
    Morillas-Arques, Piedad
    Ma Rodriguez-Lopez, Carmen
    Molina-Barea, Rocio
    Rico-Villademoros, Fernando
    Calandre, Elena P.
    [J]. BMC MUSCULOSKELETAL DISORDERS, 2010, 11
  • [7] Trazodone for the treatment of fibromyalgia: an open-label, 12-week study
    Piedad Morillas-Arques
    Carmen Ma Rodriguez-Lopez
    Rocio Molina-Barea
    Fernando Rico-Villademoros
    Elena P Calandre
    [J]. BMC Musculoskeletal Disorders, 11
  • [8] EFFICACY AND SAFETY OF DIFFERENT SCHEMES OF ETORICOXIB ADMINISTRATION IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS - RESULTS OF A 12-WEEK, PROSPECTIVE, OPEN-LABEL STUDY
    Gaydukova, I.
    Rebrov, A.
    Nikitina, N.
    Nam, I.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 718 - 718
  • [9] Effectiveness of Lurasidone 80 mg in Patients with Schizophrenia: Results of an Open-Label, 12-Week Extension Study
    Miura, Itaru
    Watabe, Kei
    Sakaguchi, Reiko
    Okamoto, Keisuke
    Maruyama, Hidenori
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2022, 18 : 2627 - 2637
  • [10] Safety and Tolerability of Dextromethorphan/Quinidine for Pseudobulbar Affect in a 12-Week, Open-Label Extension Study
    Pioro, Erik
    Brooks, Benjamin
    Cummings, Jeffrey
    Schiffer, Randolph
    Wynn, Daniel
    Hepner, Adrian
    Viejo, Aliso
    Kaye, Randall
    [J]. NEUROLOGY, 2010, 74 (09) : A541 - A541
12345